Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Scopus BioPharma Inc. (SCPS)
|
Add to portfolio |
|
|
|
| Price: |
$1.70
| | Metrics |
| OS: |
42.1
|
M
| |
|
|
| Market cap: |
$71.5
|
M
| |
|
|
|
Net cash:
|
$362.1
|
k
| |
$0.01
|
per share
|
|
EV:
|
$71.2
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Research and development | 15.0 | 7.4 | 0.5 |
| General and administrative | 12.6 | 2.7 | 2.2 |
| EBIT | -27.6 | -10.2 | -2.7 |
| Pre-tax income | -27.0 | -10.9 | -2.7 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -27.0 | -10.9 | -2.7 |
| |
| Diluted EPS | ($1.56) | ($0.81) | ($0.22) |
| Shares outstanding (diluted) | 17.3 | 13.4 | 12.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|